CymaBay Therapeutics Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (31)

Latest Posts

About This Stock More About This Stock
'Underwhelming' Intercept Data Hurts CymaBay Bear Thesis, Says Piper Jaffray
Article By: The Fly
Wednesday, February 20, 2019 5:48 AM EDT
A major constituent of the CymaBay bear thesis has now been removed.
In this article: CBAY Also: ICPT
Read
Why Are Top Analysts Obsessed With These 3 Disruptive Stocks?
Article By: TipRanks
Sunday, December 3, 2017 12:53 PM EDT
Here we focus in on three stocks that have the power to disrupt- and have significant backing from the Street. All these stocks have a ‘Strong Buy’ rating from the best-performing analysts- and big upside potential from the current share price.
In this article: AMZN, CBAY, SEDG
Read
CymaBay Announces Pricing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Wednesday, July 19, 2017 1:19 PM EDT
CymaBay Therapeutics, Inc., today announced the pricing of its previously announced underwritten public offering of 13,000,000 shares of its common stock at a public offering price of $6.50 per share.
In this article: CBAY
Read
5 Breakout Stocks For Superior Returns
Article By: Swarup Gupta
Friday, February 10, 2017 10:50 AM EDT
Utilizing a breakout investment strategy is a favored choice of active investors who are content only with returns superior to most other investments.
In this article: GNK, CBAY, CMRX, SMMT, MODN
Read
2 Biotech Lottery Tickets For Under $5
Article By: Bret Jensen
Tuesday, September 15, 2015 9:49 PM EDT
The high beta biotech sector has started to recover in recent weeks after almost dropping 20% from previous highs and thus avoiding an official “bear” market.
In this article: THLD, CBAY Also: AMGN, GILD
Read

PARTNER HEADLINES

Latest Tweets for $CBAY

No tweets yet!